Cargando…
376. Long Term Outcomes of a Pilot Single-Blinded, Randomized Controlled Trial Comparing BNT162b2 vs JNJ-78436735 Vaccine as the Third Dose after Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients
BACKGROUND: Due to immunosuppressive medication, the immunogenicity after COVID-19 vaccination is suboptimal and durability in Solid Organ Transplant (SOT) recipients is still questionable. Thus, booster dose has been studied to improve not only the short but also long-term immunogenicity. However,...
Autores principales: | Natori, Yoichiro, Martin, Eric F, Mattiazzi, Adela, Sota, Katherine Alexandra, Viotti, Julia Bini, Anjan, Shweta, Guerra, Giselle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678189/ http://dx.doi.org/10.1093/ofid/ofad500.446 |
Ejemplares similares
-
A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients
por: Natori, Yoichiro, et al.
Publicado: (2023) -
The Safety of mRNA-1273, BNT162b2 and JNJ-78436735 COVID-19 Vaccines: Safety Monitoring for Adverse Events Using Real-World Data
por: Sa, Soonok, et al.
Publicado: (2022) -
Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant
por: Eick-Cost, Angelia A., et al.
Publicado: (2022) -
Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort
por: Bürzle, Oliver, et al.
Publicado: (2023) -
CoronaVac or BNT162b2 Vaccine as a Third Dose
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)